3D bioprinting breakthrough in vascular systems

Latest articles

Cellino bags $80 million to autonomise stem cell therapy manufacturing

Leaps by Bayer leads $80m Series A to enable Cellino to significantly expand patient access to stem cell-based therapies. Cellino Biotech, Inc, an autonomous stem cell...

“World’s first” cultural-matching app for care sector launches

Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic. A graduate has created what...

Biotech LyGenesis expands its liver regeneration tech

A new peer-reviewed paper demonstrates the success of using fat-associated lymphoid clusters as expandable niches for ectopic liver regeneration. LyGenesis, a clinical-stage biotech developing cell...

NURO embarks on funding round for neurotech communication system

World’s first multimodal neurotech operating system from NURO allows you to communicate using just your brain. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Cellino bags $80 million to autonomise stem cell therapy manufacturing

Leaps by Bayer leads $80m Series A to enable Cellino to significantly expand patient access to stem cell-based therapies. Cellino Biotech, Inc, an autonomous stem cell...

“World’s first” cultural-matching app for care sector launches

Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic. A graduate has created what...

Biotech LyGenesis expands its liver regeneration tech

A new peer-reviewed paper demonstrates the success of using fat-associated lymphoid clusters as expandable niches for ectopic liver regeneration. LyGenesis, a clinical-stage biotech developing cell...

Click the globe for translations.

Researchers develop breakthrough in 3D bioprinting blood networks with functioning skin.

The field of 3D bioprinting has shown great advancements toward the production of artificial organs that will work much like their biological counterparts. However, there has been one major hurdle: finding a way to create functioning blood vessels that supply the necessary nutrients to the organ. New research from the Rensselaer Polytechnic Institute in New York may have found the answer to this dilemma, with a new technique to 3D-print living skin with complete vascular networks.

While some artificial 3D-printed skin grafts are commercially available today, they do not last long and eventually fall off. This is mostly due to a lack of a vasculature system to feed the graft. “Right now, whatever is available as a clinical product is more like a fancy Band-Aid,” said Professor Pankaj Karande, member of the Center for Biotechnology and Interdisciplinary Studies (CBIS), who led the research. [1]

The Rensselaer Polytechnic Institute’s latest breakthrough consists of using a skin graft and combining it with more types of cells, including melanocytes and endothelial cells with pericytes, which form functional vasculature in the lab when the tissue is printed. The graft with the added cells was tested on animal wounds and was found to integrate well with the animal’s skin and tissue.

The TRL score for this Longevity.Technology domain is currently set at: ‘Early proof of concept demonstrated in the laboratory.’

The TRL score for the technology addressed in this article is: “Late proof of concept demonstrated in real life conditions.”

The new technique was tested by Yale researchers who grafted the artificial skin onto mice. The results showed that the artificial graft with the lab-made blood vessels created connections with the biological blood vessels in the mice. The integration is an important step as without blood and the flow of nutrients, a skin graft would die very quickly. Recreating biology is a very complex process, but new platforms and technology like 3D-bioprinting are making it easier and allowing researchers to build cellular structures that mimic human biology with greater precision and accuracy.

“We were pleasantly surprised to find that, once we start approaching that complexity, biology takes over and starts getting closer and closer to what exists in nature.” said Karande.

The 3D-printed living skin with blood vessels is currently in animal trials and is still in need of adjustment for humans to make it workable at a clinical level. For the process to work in humans effectively, it would require the combination of both 3D-bioprinting and gene editing technology such as CRISPR to work. Editing a patient’s donor cells would ensure that the artificial blood vessels could fully integrate and would not be rejected by the patient’s body.

“This significant development highlights the vast potential of 3D bioprinting in precision medicine, where solutions can be tailored to specific situations and eventually to individuals,” said Deepak Vashishth, the director of the Center for Biotechnology and Interdisciplinary Studies (CBIS).

So will full artificial organs and skin with lab-made blood vessels be hitting the market soon? “We are still not at that step, but we are one step closer,” Karande said. Despite it not being ready for the market just yet, this is a important milestone for the 3D-bioprinting field and brings the possibilities of new therapies and deceasing transplant lists closer than ever before. 

So what’s next? More research is required to get the skin graft into humans trials and to incorporate a CRISPR element into the mix. In the field of 3D-bioprinting, this discovery opens up a wealth of opportunities and makes way for the creation of more complex artificial cellular structures that could one day match our biological organs.

[1] https://scienceblog.com/511822/living-skin-can-now-be-3d-printed-with-blood-vessels-included/

Image: Jay Yuan / Shutterstock
Salvinija Roznyte
Staff Writer Salvinija Roznyte is a writer and journalist based in London. She graduated in 2018 with a Bachelor's degree majoring in Writing and Journalism with a minor in Film Studies. She is interested in the way modern medical technology changes and shapes our world.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Sugar-proof your health with the GLYLO weight loss and antiaging supplement

Move your New Year's resolution up a gear with GLYLO, a double-action supplement that can increase weight loss while also slowing aging. Choosing an effective...

Related articles

Exercise protects brain against Alzheimer’s by safeguarding synapses

UCSF researchers find enhanced nerve transmission is seen in older adults who remain active. When elderly people stay active, their brains have more of a...

Cytosurge wins funding to address bottlenecks in neuroscience research

R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding from Innosuisse. Cytosurge, a provider...

Kitalys Institute: breaking down the barriers to longevity clinical trials

Institute's founder calls for regulatory changes to allow geroscience innovation to flourish and enable true longevity trials. “Preserve health, prevent disease, prolong healthspan,” begins the...

New partnership to accelerate microbiome analysis with AI augmentation

Eagle Genomics and Quadram Institute’s new strategic partnership set to accelerate microbiome analysis through AI-augmented knowledge discovery platform. Today, Eagle Genomics, the Deep Tech software business...

New study reveals ways to help protect bones as we age

Tackling aging sometimes needs a left-field approach – especially when it comes to protecting our bones. Aging affects us right down to our bones; bone...

    Subscribe to our newsletter